{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:07:32Z","timestamp":1791310052043,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jocn.2013.01.032","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T21:45:23Z","timestamp":1384206323000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types"],"prefix":"10.1016","volume":"21","author":[{"given":"Youxin","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.01.032_b0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jocn.2004.01.002","article-title":"A pilot study of compassionate use of levetiracetam in patients with generalised epilepsy","volume":"11","author":"Weber","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2013.01.032_b0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/14740338.6.3.241","article-title":"The safety of levetiracetam","volume":"6","author":"Sirsi","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jocn.2013.01.032_b0015","first-page":"489","article-title":"Levetiracetam: a review of its use in epilepsy","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jocn.2013.01.032_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/ern.10.3","article-title":"Levetiracetam: a comprehensive review","volume":"10","author":"Crepeau","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jocn.2013.01.032_b0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1528-1167.2008.01817.x","article-title":"Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial","volume":"50","author":"Peltola","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0030","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy","volume":"69","author":"Berkovic","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.01.032_b0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.01.032_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/seiz.2000.0380","article-title":"A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy","volume":"9","author":"Betts","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2013.01.032_b0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000197109","article-title":"Efficacy and safety of levetiracetam (3,000 mg\/day) as an adjunctive therapy in Chinese patients with refractory partial seizures","volume":"61","author":"Xiao","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2013.01.032_b0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1528-1167.2008.01729.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures","volume":"50","author":"Wu","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0055","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.01.032_b0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures","volume":"50","author":"Pi\u00f1a-Garza","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00323-0","article-title":"Dose-response effect of LEV 1000 and 2000 mg\/day in partial epilepsy","volume":"48","author":"Boon","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2013.01.032_b0070","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam study group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.01.032_b0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2006.00372.x","article-title":"Efficacy and safety of Levetiracetam (up to 2000 mg\/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study","volume":"47","author":"Tsai","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0085","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of LEV as add-on therapy in patients with refractory partial seizures. European LEV study group","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yebeh.2009.08.026","article-title":"Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study","volume":"16","author":"Wu","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2013.01.032_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2010.06.002","article-title":"Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial","volume":"90","author":"Tonekaboni","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2013.01.032_b0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1212\/01.wnl.0000313151.64005.c0","article-title":"Tolerability and efficacy of oral loading of levetiracetam","volume":"70","author":"Koubeissi","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.01.032_b0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/11316250-000000000-00000","article-title":"Levetiracetam in childhood epilepsy","volume":"12","author":"Verrotti","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jocn.2013.01.032_b0110","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1528-1167.2011.03047.x","article-title":"Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis","volume":"52","author":"Costa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.01.032_b0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1528-1167.2010.02976.x","article-title":"A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy","volume":"52","author":"Fattore","year":"2011","journal-title":"Epilepsia"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T22:23:51Z","timestamp":1539210231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586813002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0967586813002385"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.01.032","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}